Health

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24 Minutes

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving discoveries SINGAPORE, Sept. 19, 2025 /PRNewswire/ -- Lenovo today shared updates on the 4th generation of its Genomics Optimization and Scalability Tool –GOAST v4.0. Since its...

2025-09-19 16:58 1818

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24 Minutes

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving discoveries CANBERRA, Australia, Sept. 19, 2025 /PRNewswire/ -- Lenovo today shared updates on the 4th generation of its Genomics Optimization and Scalability Tool –GOAST v4.0....

2025-09-19 16:51 1720

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24 Minutes

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving discoveries MANILA, Philippines, Sept. 19, 2025 /PRNewswire/ -- Lenovo today shared updates on the 4th generation of its Genomics Optimization and Scalability Tool –GOAST v4.0....

2025-09-19 16:04 1823

International Doctors Visit Smartee HQ and Share Insights on Next-Generation Orthodontics

SHANGHAI, Sept. 19, 2025 /PRNewswire/ -- Smartee Denti-Technology hosted a delegation of orthodontic specialists fromEurope and Asia at its Shanghai headquarters and digital production facilities. The visit combined advanced mandibular repositioning lectures, clinical visits, and cultural exchang...

2025-09-19 14:35 1747

SingHealth's Healthier EAST @ SG joins WHO's Global Network of Age-Friendly Cities

* Healthier EAST @ SG, a comprehensive, multi-agency initiative led by SingHealth, has been inducted into the World Health Organization (WHO)'s Global Network for Age-Friendly Cities and Communities (GNAFCC). * The landmark initiative impacts over 610,000 residents in the east of Singapore th...

2025-09-19 10:00 2744

2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment

SHANGHAI, NANJING, China and PLEASANTON, Calif., Sept. 18, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announced that the 36-month long-term foll...

2025-09-19 09:39 1978

LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic Services

JOHNSON CITY, Tenn., Sept. 19, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Bill Finger as Senior Vice President, Global Strategic Services, effectiveWednesday, September 10, 2025.  Bill brings more than 25 years of diagnostics and clinical research experience, with ...

2025-09-19 01:25 1875

QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025

* Patients who received zovaglutide at a once-monthly dose of 160 mg experienced a 13.8% reduction in body weight at 24 weeks, highly comparable to reductions observed in patients who received 80 mg every other week (12.5%) * The overall safety and tolerability of zovaglutide were consistent ...

2025-09-18 21:00 1668

NYSE Content Advisory: Pre-Market Update + Fed cuts interest rates by 0.25%

NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Fed cuts interest ra...

2025-09-18 20:55 3805

Beyond Ventures Champions HKIC's new initiatives outlined in The Policy Address 2025

Strategic partnership with the HKIC fuels growth across biotech, hardcore and greentech sectors, reinforcingHong Kong's role as a super-connector and super value-adder in the global innovation landscape HONG KONG, Sept. 18, 2025 /PRNewswire/ -- Hong Kong-based venture capital firm Beyond Venture...

2025-09-18 17:57 2016

Grace Lu rejoining Russell Reynolds Associates Singapore as Managing Director for Healthcare Practice

SINGAPORE, Sept. 18, 2025 /PRNewswire/ -- Russell Reynolds Associates  (RRA), the leading global leadership advisory firm, is pleased to announce thatGrace Lu is rejoining theSingapore ...

2025-09-18 14:34 1736

Investing in Futures: Education Cannot Wait Reaches 14 Million Children in Crises Worldwide

New ECW Results Report highlights transformative education outcomes for children and adolescents in emergencies and protracted crises and calls for urgent funding to sustain progress. NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Education Cannot Wait (ECW

2025-09-18 12:00 1954

Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2)

SAN FRANCISCO and SUZHOU, China, Sept. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...

2025-09-18 12:00 1742

Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway

Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 17, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings...

2025-09-18 10:28 1737

/C O R R E C T I O N -- CAIR/

In the news release, "EchoCare" Ultrasound Large Model Launched in Hong Kong as CAIR Showcases Large-Scale Ultrasound Dataset Training Achievements, issued 17-Sep-2025 by CAIR over PR Newswire, we are advised by the company that the headline, 2nd paragraph, 6th paragraph, and 7th paragraph have be...

2025-09-18 10:22 2720

Sunway Medical Centre named Top Malaysian Smart Hospital in Newsweek's World's Best Smart Hospitals 2026 ranking

SUNWAY CITY, Malaysia, Sept. 18, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC) has been honoured as top Malaysian hospital and debuted in the top 350 hospitals in the world, as per the latest Newsweek's World's Best Smart Hospitals 2026 ranking.

2025-09-18 09:00 2637

Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting

YANTAI, China, Sept. 18, 2025 /PRNewswire/ -- RemeGen (688331.SH/09995.HK) announced that the 48-week open-label extension (OLE) data from China Phase III clinical study of telitacicept (RC18, brand name: 泰爱®, a BLyS/APRIL dual-target fusion protein innovative drug independently developed by Reme...

2025-09-18 09:00 1779

CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025

SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the updated long-term follow-up results of Phase I clinical trial of zevorcabtagene autoleucel (zevor-cel, R&D code...

2025-09-18 08:15 2010

Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025

--Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. --Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. Treatment emergent adverse events (TEAEs)...

2025-09-18 07:30 1686

MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine.

* First-ever clinical data supporting safety and efficacy of in vivo CAR-T Therapy in refractory systemic lupus erythematosus (SLE) patients. * Data shows low dose of HN2301 reprogrammed up to 60% of CD8+ CAR+ T-cells in the peripheral blood of patients, resulting in complete depletion of cir...

2025-09-18 05:09 1454
1 ... 45464748495051 ... 873

Week's Top Stories